SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-18-008683
Filing Date
2018-02-15
Accepted
2018-02-15 16:26:02
Documents
1
Period of Report
2018-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 5124
  Complete submission text file 0001140361-18-008683.txt   6827
Mailing Address 395 OYSTER POINT BLVD., SUITE 405 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BLVD., SUITE 405 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Issuer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CARE CAPITAL LLC 47 HULFISH STREET, SUITE 310 PRINCETON NJ 08542
Business Address
Markham Richard J (Reporting) CIK: 0001362743 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35285 | Film No.: 18618026